DDW 2009 marked another important milestone for probe-based Confocal Laser Endomicroscopy (pCLE) and for Cellvizio.
The Cellvizio blimp flew high over our booth, as our international team welcomed constant visits from leading physicians around the world.
We were excited to hear about our customers' promising pCLE projects and to discuss new partnerships with others.
Please find below an update about new Cellvizio users and initiatives.
We wish you all a very sunny summer and look forward to helping you build the field of pCLE.
Sacha Loiseau, PhD,
President, CEO and Founder
|
| |
|
Training Opportunities
Several pCLE Centers of Excellence in the US and Europe now offer intensive, one-and-a-half day training workshops.
Please contact us at
brian@maunakeatech.com (US workshops) or
anne@maunakeatech.com (European workshops)
in order to learn more about our upcoming training calen- dar.
|
|
 |
|
| |
|
Don't miss CNBC's profile on Mauna Kea Technologies,
"Medicine under the micros- cope" shot in Paris last April.
Click here.
Cellvizio was also included in Forbes' recent review of "Tech That Could Save Your Life."
Click here
for the story and
here
for the accompanying images.
|
|
|
|
| |
|
Since our last update regar- ding new sites, Cellvizio has been installed at several world renowned medical institutions, including:
Brigham & Women's Hospital,
Boston, USA
Cedars Sinai Medical Center,
Los Angeles, USA
Cleveland Clinic,
USA
Cochin Hospital,
Paris, France
Mayo Clinic - Scottsdale,
USA
Princesse Grace Medical Center,
Monaco
University of California,
Irvine, USA
University of Chicago,
USA
University Hospital,
Düsseldorf, Germany
University Hospital,
Erlangen, Germany
University Hospital,
Greifswald, Germany
University Medical Center,
Toulouse, France
University of Washington,
Seattle, USA
UZ Leuven,
Belgium
|
|
|
|
|
|
|
34 Cellvizio Studies Presented
|
Through 34 presentations and posters on specific Cellvizio studies and more than 50 communications on Confocal
Laser Endomicroscopy, key opinion leaders from many countries expressed the usefulness and importance
of our product. Importantly, a growing body of data shows that Cellvizio can effectively rule out early esophageal cancer.
|
|
About half of the scientific communications were reported by US based physicians,
and there were almost as many oral presentations as posters.
Colon and esophageal applications accounted for almost half of all studies presented.
Click here for a complete list of the DDW presentations featuring Cellvizio.
|
|
 |
|
|
|
|
|
|
MKT Launches Cellvizio.net
Education Section
As part of our continuing efforts to provide our users with support and tools to better understand pCLE,
we have added teaching and training initiatives to the new education section on
Cellvizio.net.
The teaching section includes didactic slides on pCLE image interpretation,
while the training section enables users to test their performance and receive instant feedback
to improve their image interpretation skills.
Please
click here to read more about how to use this
new section of the website
and do not hesitate to request a login and password.
|
|
|
|
